Pfizer and Sangamo initiate dosing in Phase III haemophilia A trial,

Recent data from the Phase I/II Alta trial showed clinically meaningful factor levels and decreased bleeds, with giroctocogene fitelparvovec generally …, Recent data from the Phase I/II Alta trial showed clinically meaningful factor levels and decreased bleeds, with giroctocogene fitelparvovec generally …, Read More